After 4 weeks of observation, the volume and weight of tumours in the Mist1-overexpressing group were significantly decreased, indicating that Mist1 could inhibit gastric cancer growth in vivo (Fig. 2I). This evidence concerns the gene BHLHA15 and neoplasm.